🔗 Share this article

The top legal official in Texas Ken Paxton is suing the makers of Tylenol, asserting the companies concealed potential risks that the drug posed to children's brain development.

This legal action comes a month after Former President Trump promoted an unproven link between taking Tylenol - referred to as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is suing the pharmaceutical giant, which once produced the drug, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a statement, he said they "deceived the public by making money from pain and pushing pills without regard for the potential hazards."

The company asserts there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, intentionally threatening millions to boost earnings," the attorney general, a Republican, said.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the health of American women and children."

On its official site, Kenvue also said it had "consistently assessed the applicable studies and there is no credible data that demonstrates a proven link between consuming acetaminophen and autism spectrum disorder."

Groups speaking for doctors and health professionals share this view.

ACOG has stated paracetamol - the main ingredient in acetaminophen - is one of the few options for pregnant women to address discomfort and fever, which can pose significant medical dangers if ignored.

"In more than two decades of studies on the utilization of acetaminophen in gestation, not a single reputable study has successfully concluded that the consumption of paracetamol in any stage of gestation leads to neurodevelopmental disorders in children," the organization commented.

The lawsuit references recent announcements from the Trump administration in asserting the medication is allegedly unsafe.

Recently, Trump generated worry from public health officials when he told women during pregnancy to "struggle intensely" not to take Tylenol when sick.

The FDA then released a statement that physicians should consider limiting the usage of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in minors has not been proven.

The Health Department head Kennedy, who oversees the FDA, had pledged in April to conduct "a massive testing and research effort" that would determine the origin of autism in a limited time.

But authorities cautioned that finding a sole reason of autism - believed by scientists to be the outcome of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and condition that affects how persons experience and relate to the surroundings, and is diagnosed using doctors' observations.

In his legal document, Paxton - a Trump ally who is seeking federal office - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the corporations "eliminate any marketing or advertising" that asserts Tylenol is safe for expectant mothers.

This legal action mirrors the concerns of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in recently.

A federal judge threw out the case, stating studies from the family's specialists was not conclusive.